Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pathophysiol. Nov 15, 2014; 5(4): 438-449
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.438
Published online Nov 15, 2014. doi: 10.4291/wjgp.v5.i4.438
Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus
Michael Bennett, Hiroshi Mashimo, Veterans Health Administration Boston Healthcare System, Harvard Medical School, Boston, MA 02132, United States
Hiroshi Mashimo, Department of Medicine/Gastroenterology, VA Boston Healthcare System, West Roxbury, MA 02132, United States
Author contributions: Bennett M and Mashimo H solely contributed to this paper.
Correspondence to: Hiroshi Mashimo, MD, PhD, Department of Medicine/Gastroenterology, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA 02132, United States. hmashimo@hms.harvard.edu
Telephone: +1-857-2035640 Fax: +1-857-2035640
Received: January 29, 2014
Revised: April 10, 2014
Accepted: July 12, 2014
Published online: November 15, 2014
Processing time: 293 Days and 15.8 Hours
Revised: April 10, 2014
Accepted: July 12, 2014
Published online: November 15, 2014
Processing time: 293 Days and 15.8 Hours
Core Tip
Core tip: This review highlights recent advances and future directions in biomarker development and endoscopic imaging technology for identification of patients at risk of malignant progression of Barrett’s esophagus.